Skip to content

Study on the treatment of diarrhea-predominant irritable bowel syndrome with Xifenghuashi Granules through changes in intestinal flora

Study on the treatment of diarrhea-predominant irritable bowel syndrome with Xifenghuashi Granules through changes in intestinal flora

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045943
Enrollment
Unknown
Registered
2021-04-29
Start date
2021-04-26
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diarrhea-predominant irritable bowel syndrome

Interventions

Sponsors

Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Conform to western medical diagnostic criteria of IBS-D; 2. Conform to diagnostic criteria of TCM syndromes of liver depression and spleen deficiency; 3. Aged 18 to 70 years, gender is not limited; 4. Subjects voluntarily participate in the trial and sign informed consent; 5. The process of obtaining informed consent should conform to ethical principles.

Exclusion criteria

Exclusion criteria: 1. Patients with organic gastrointestinal diseases; 2. Patients with severe heart, liver, kidney, respiratory, blood, and endocrine diseases; 3. Patients with mental illness and severe neurosis; 4. Women who are pregnant, breast-feeding or planning to have a pregnancy; 5. Those who have taken antibiotics or probiotics or gastrointestinal motility drugs within 1 month before being included in the trial; 6. Patients who have poor compliance with doctor's orders or are allergic to this medicine; 7. Patients who are participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
intestinal flora;

Secondary

MeasureTime frame
efficacy index;mental state and quality of life assessment indicators;

Countries

China

Contacts

Public ContactLi Hui

Affiliated Hospital of Integrated Traditional Chinese and Western Medicine for Nanjing University of Chinese Medicine

llynlh_1981@163.com+86 17601558686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026